omerbasket
Senior Member
- Messages
- 510
Because of the thread here yesterday, where I talked about the BWG study not using Trizol or any other preservatives, I asked Dr. Mikovits yesterday questions via email, and she responded. I think that her answer is very important.
This was my question:
And this was her answer:
So, what Dr. Mikovits says is the following:
1) The purpose of the BWG was to develope a test that would suite testing the blood supply. That means that you cannot use whatever procedures you think are the best, you can use only procedures that would suite testing blood donations for the blood supply.
2) As opposed to that, the Lipkin study is designed to test whether the association of HGRV to ME/CFS is correct, and there the WPI would be able to do erverything (I think) as they want to.
This was my question:
On Facebook, "XMRV Global Advocacy" wrote, about the Blood Working Group study, that "The PMBCs were not preserved in Trizol or any other preserving agent. Any virus would be dead!". What I would like to ask you is: Do you think that using Trizol would have made a difference? And, on a broader spectrum, do you think that different collection and processing procedures should have been applied?
If any of the answers for these is "yes", would the Lipkin study make sure that validated collection and processing procedures would be used?
And this was her answer:
The blood working groups' goal was to develop assays to test the blood supply as it is..that means plasma and whole blood and buffy coats..The results do not say that HGRVs are not in the blood (it) simply (says that they are) at levels too low to detect in the samples as they are saved in blood banks world-wide. This was not a study to determine the association of XMRVs/HGRVs to disease..it was intended to determine if the blood supply is safe
The Lipkin study will use all the collection procedures exactly as we specified..and that study will determine the association.
So, what Dr. Mikovits says is the following:
1) The purpose of the BWG was to develope a test that would suite testing the blood supply. That means that you cannot use whatever procedures you think are the best, you can use only procedures that would suite testing blood donations for the blood supply.
2) As opposed to that, the Lipkin study is designed to test whether the association of HGRV to ME/CFS is correct, and there the WPI would be able to do erverything (I think) as they want to.